BIOMARIN PHARMACEUTICAL INC Increase (Decrease) in Other Current Assets
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Increase (Decrease) in Other Current Assets of $23.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other current assets for the quarter ending 2026-06-30 was $12.04M, a 37.34% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other current assets for the quarter ending 2026-03-31 was $11.55M, a 82.57% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$41.02M.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other current assets for the quarter ending 2025-09-30 was $17.03M, a 20.98% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other current assets for fiscal 2025 was -$8.89M, a 335.34% decline from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other current assets for fiscal 2024 was $3.78M, a 92.49% decline from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other current assets for fiscal 2023 was $50.34M.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in other current assets for fiscal 2022 was -$7.82M.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $23.59M 10-Q · filed 2026-08-06 | -$17.43M derived: sum of 3 quarters · filed 2026-08-06 | -$394.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $11.55M 10-Q · filed 2026-05-05 | -$29.46M derived: sum of 2 quarters · filed 2026-05-05 | -$12.43M derived: sum of 3 quarters · filed 2026-05-05 | -$3.67M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$41.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$23.98M derived: sum of 2 quarters · filed 2026-02-26 | -$15.22M derived: sum of 3 quarters · filed 2026-08-06 | -$8.89M 10-K · filed 2026-02-26 |
| 2025-09-30 | $17.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $25.80M derived: sum of 2 quarters · filed 2026-08-06 | $32.13M 10-Q · filed 2025-10-28 | $15.96M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $8.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $15.09M 10-Q · filed 2026-08-06 | -$1.07M derived: sum of 3 quarters · filed 2026-08-06 | $20.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $6.33M 10-Q · filed 2026-05-05 | -$9.83M derived: sum of 2 quarters · filed 2026-05-05 | $11.72M derived: sum of 3 quarters · filed 2026-05-05 | -$7.25M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$16.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.39M derived: sum of 2 quarters · filed 2026-02-26 | -$13.57M derived: sum of 3 quarters · filed 2026-02-26 | $3.78M 10-K · filed 2026-02-26 |
| 2024-09-30 | $21.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $2.59M derived: sum of 2 quarters · filed 2025-10-28 | $19.94M 10-Q · filed 2025-10-28 | $10.88M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$18.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$1.61M 10-Q · filed 2025-08-05 | -$10.67M derived: sum of 3 quarters · filed 2026-02-26 | -$4.71M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $17.35M 10-Q · filed 2025-05-02 | $8.30M derived: sum of 2 quarters · filed 2026-02-26 | $14.26M derived: sum of 3 quarters · filed 2026-02-26 | $31.69M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$9.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.10M derived: sum of 2 quarters · filed 2026-02-26 | $14.33M derived: sum of 3 quarters · filed 2026-02-26 | $50.34M 10-K · filed 2026-02-26 |
| 2023-09-30 | $5.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $23.39M derived: sum of 2 quarters · filed 2024-10-31 | $59.39M 10-Q · filed 2024-10-31 | $43.01M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-06-30 | $17.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $53.43M 10-Q · filed 2024-08-05 | $37.05M derived: sum of 3 quarters · filed 2025-02-24 | $33.61M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-03-31 | $36.00M 10-Q · filed 2024-04-26 | $19.62M derived: sum of 2 quarters · filed 2025-02-24 | $16.18M derived: sum of 3 quarters · filed 2025-02-24 | $20.17M derived: sum of 4 quarters · filed 2025-02-24 |
| 2022-12-31 | -$16.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | -$19.82M derived: sum of 2 quarters · filed 2025-02-24 | -$15.83M derived: sum of 3 quarters · filed 2025-02-24 | -$7.82M 10-K · filed 2025-02-24 |
| 2022-09-30 | -$3.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $547.00K derived: sum of 2 quarters · filed 2023-11-02 | $8.56M 10-Q · filed 2023-11-02 | $5.83M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $3.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $12.00M 10-Q · filed 2023-08-02 | $9.27M derived: sum of 3 quarters · filed 2024-02-26 | $16.57M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $8.01M 10-Q · filed 2023-04-28 | $5.28M derived: sum of 2 quarters · filed 2024-02-26 | $12.58M derived: sum of 3 quarters · filed 2024-02-26 | $21.04M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | -$2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $4.57M derived: sum of 2 quarters · filed 2024-02-26 | $13.02M derived: sum of 3 quarters · filed 2024-02-26 | -$29.76M 10-K · filed 2024-02-26 |
| 2021-09-30 | $7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $15.76M derived: sum of 2 quarters · filed 2022-10-28 | -$27.03M 10-Q · filed 2022-10-28 | -$12.49M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $8.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$34.33M 10-Q · filed 2022-08-04 | -$19.80M derived: sum of 3 quarters · filed 2023-02-27 | -$32.20M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$42.78M 10-Q · filed 2022-04-29 | -$28.25M derived: sum of 2 quarters · filed 2023-02-27 | -$40.66M derived: sum of 3 quarters · filed 2023-02-27 | -$52.79M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $14.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $2.13M derived: sum of 2 quarters · filed 2023-02-27 | -$10.01M derived: sum of 3 quarters · filed 2023-02-27 | -$18.31M 10-K · filed 2023-02-27 |
| 2020-09-30 | -$12.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$24.55M derived: sum of 2 quarters · filed 2021-10-29 | -$32.85M 10-Q · filed 2021-10-29 | -$19.10M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | -$12.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$20.44M 10-Q · filed 2021-07-30 | -$6.69M derived: sum of 3 quarters · filed 2022-02-25 | $1.58M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$8.30M 10-Q · filed 2021-04-30 | $5.45M derived: sum of 2 quarters · filed 2022-02-25 | $13.72M derived: sum of 3 quarters · filed 2022-02-25 | $28.82M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $13.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $22.02M derived: sum of 2 quarters · filed 2022-02-25 | $37.12M derived: sum of 3 quarters · filed 2022-02-25 | $27.01M 10-K · filed 2022-02-25 |
| 2019-09-30 | $8.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $23.37M derived: sum of 2 quarters · filed 2020-11-06 | $13.26M 10-Q · filed 2020-11-06 | $35.30M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $15.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $4.99M 10-Q · filed 2020-08-05 | $27.03M derived: sum of 3 quarters · filed 2021-02-26 | $20.72M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$10.11M 10-Q · filed 2020-05-01 | $11.93M derived: sum of 2 quarters · filed 2021-02-26 | $5.62M derived: sum of 3 quarters · filed 2021-02-26 | $10.58M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $22.04M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $15.73M derived: sum of 2 quarters · filed 2021-02-26 | $20.69M derived: sum of 3 quarters · filed 2021-02-26 | $17.77M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$6.31M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04 | -$1.35M derived: sum of 2 quarters · filed 2019-11-04 | -$4.28M 10-Q/A · filed 2019-11-04 | -$4.38M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $2.04M 10-Q · filed 2019-08-02 | $1.94M derived: sum of 3 quarters · filed 2020-02-27 | $19.01M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$2.92M 10-Q · filed 2019-04-29 | -$3.02M derived: sum of 2 quarters · filed 2020-02-27 | $14.05M derived: sum of 3 quarters · filed 2020-02-27 | $20.53M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $16.98M derived: sum of 2 quarters · filed 2020-02-27 | $23.45M derived: sum of 3 quarters · filed 2020-02-27 | $20.69M 10-K · filed 2020-02-27 |
| 2017-09-30 | $17.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $23.55M derived: sum of 2 quarters · filed 2018-10-26 | $20.79M 10-Q · filed 2018-10-26 | -$85.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $6.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $3.71M 10-Q · filed 2018-08-03 | -$17.16M derived: sum of 3 quarters · filed 2019-02-28 | -$12.42M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$2.76M 10-Q · filed 2018-04-27 | -$23.64M derived: sum of 2 quarters · filed 2019-02-28 | -$18.89M derived: sum of 3 quarters · filed 2019-02-28 | -$19.68M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$20.87M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$16.13M derived: sum of 2 quarters · filed 2019-02-28 | -$16.92M derived: sum of 3 quarters · filed 2019-02-28 | -$19.32M 10-K · filed 2019-02-28 |
| 2016-09-30 | $4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $3.96M derived: sum of 2 quarters · filed 2017-10-31 | $1.56M 10-Q · filed 2017-10-31 | -$52.21M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | -$787.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$3.19M 10-Q · filed 2017-08-02 | -$56.96M derived: sum of 3 quarters · filed 2018-02-26 | -$26.77M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | -$2.40M 10-Q · filed 2017-05-04 | -$56.17M derived: sum of 2 quarters · filed 2018-02-26 | -$25.99M derived: sum of 3 quarters · filed 2018-02-26 | -$31.72M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | -$53.77M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$23.59M derived: sum of 2 quarters · filed 2018-02-26 | -$29.32M derived: sum of 3 quarters · filed 2018-02-26 | -$25.80M 10-K · filed 2018-02-26 |
| 2015-09-30 | $30.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $24.45M derived: sum of 2 quarters · filed 2016-11-03 | $27.97M 10-Q · filed 2016-11-03 | $20.40M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | -$5.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$2.21M 10-Q · filed 2016-08-08 | -$9.78M derived: sum of 3 quarters · filed 2017-02-27 | $3.14M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $3.52M 10-Q · filed 2016-05-02 | -$4.05M derived: sum of 2 quarters · filed 2017-02-27 | $8.87M derived: sum of 3 quarters · filed 2017-02-27 | $4.81M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | -$7.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $5.35M derived: sum of 2 quarters · filed 2017-02-27 | $1.28M derived: sum of 3 quarters · filed 2017-02-27 | $2.21M 10-K · filed 2017-02-27 |
| 2014-09-30 | $12.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $8.86M derived: sum of 2 quarters · filed 2015-11-02 | $9.78M 10-Q · filed 2015-11-02 | $20.08M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$4.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$3.14M 10-Q · filed 2015-08-05 | $7.16M derived: sum of 3 quarters · filed 2016-02-29 | $2.57M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $927.00K 10-Q · filed 2015-05-05 | $11.22M derived: sum of 2 quarters · filed 2016-02-29 | $6.64M derived: sum of 3 quarters · filed 2016-02-29 | $4.60M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $10.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $5.71M derived: sum of 2 quarters · filed 2016-02-29 | $3.67M derived: sum of 3 quarters · filed 2016-02-29 | $12.07M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$4.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | -$6.63M derived: sum of 2 quarters · filed 2014-10-28 | $1.78M 10-Q · filed 2014-10-28 | -$2.87M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | -$2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $6.36M 10-Q · filed 2014-07-31 | $1.71M derived: sum of 3 quarters · filed 2015-03-02 | -$4.31M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $8.40M 10-Q · filed 2014-05-02 | $3.76M derived: sum of 2 quarters · filed 2015-03-02 | -$2.27M derived: sum of 3 quarters · filed 2015-03-02 | $797.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | -$4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$10.67M derived: sum of 2 quarters · filed 2015-03-02 | -$7.61M derived: sum of 3 quarters · filed 2015-03-02 | $3.51M 10-K · filed 2015-03-02 |
| 2012-09-30 | -$6.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$2.96M derived: sum of 2 quarters · filed 2013-10-28 | $8.15M 10-Q · filed 2013-10-28 | -$536.00K derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-06-30 | $3.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $14.18M 10-Q · filed 2013-07-29 | $5.49M derived: sum of 3 quarters · filed 2014-02-26 | $8.38M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-03-31 | $11.11M 10-Q · filed 2013-04-29 | $2.42M derived: sum of 2 quarters · filed 2014-02-26 | $5.31M derived: sum of 3 quarters · filed 2014-02-26 | |
| 2011-12-31 | -$8.69M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | -$5.80M derived: sum of 2 quarters · filed 2014-02-26 | -$2.54M 10-K · filed 2014-02-26 | |
| 2011-09-30 | $2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $6.15M 10-Q · filed 2012-10-29 | ||
| 2011-06-30 | $3.26M 10-Q · filed 2012-08-02 | |||
| 2010-12-31 | -$3.24M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |